Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Payers

Insurance markets showed great resiliency during the past 18 months as employment numbers fluctuated. Looking ahead, multiple legislative, regulatory, and market moves may cause shifts in the payer enrollment mix.

Partner, Health and Life Sciences, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman
Associate, Oliver Wyman

Having a deep understanding of your enrollees and the communities they in live empowers organizations to address critical needs in a meaningful way.

President and CEO, CareFirst BlueCross BlueShield Community Health Plan District of Columbia (CareFirst CHPDC)
Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

How CareFirst’s Strategic Pivot Sparked Transformation

CareFirst reflects on how an RFP, a membership surge, and a pair of acquisitions helped transform their healthcare portfolio.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Senior VP, Medicaid and Medicare Programs, CareFirst BlueCross BlueShield
VP, Segment Integration, CareFirst BlueCross BlueShield

We're entering the Great Unknown regarding health insurance enrollment mix.

Partner, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting
Associate, Oliver Wyman

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Lessons Learned and Future Visions

Humana shares its ongoing journey to make communities healthier through a personalized care approach.

VP, Bold Goal and Population Health Strategy, Humana
Partner, Health and Life Sciences, Oliver Wyman

Researchers Explore Organ Recovery and Transplantation Opportunities

Although nearly half of US adults are registered organ donors, transplant waitlists remain long. New research outlines how to accelerate improvement and offers key considerations for payers and regulators.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman

Go-to brands address society's challenges and pull us into a company's inner world. For these brands, value dictates progress.

Senior Partner, Brand Strategy, Lippincott
Partner, Lippincott
Partner, Health and Life Sciences, Oliver Wyman

With bid season approaching, payers' pharmacy teams must re-evaluate how to competitively position themselves for success.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

How extended periods of suppressed utilization and a regulatory pause on record collection may influence plans' anticipated results next year.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Advisor, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe